User menu

Human tissue allograft processing: impact on in vitro and in vivo biocompatibility.

Bibliographic reference Fawzi-Grancher, S ; Cornu, Olivier ; Goebbels, Rose-Marie ; Bigare, E ; Gianello, Pierre ; et. al. Human tissue allograft processing: impact on in vitro and in vivo biocompatibility.. In: Journal of materials science. Materials in medicine, Vol. 20, no. 8, p. 1709-20 (2009)
Permanent URL
  1. Delloye C, Cornu O, Druez V, Barbier O. Bone allografts: what they can offer and what they cannot. J Bone Joint Surg Br. 2007;89:574–9.
  2. Docquier PL, Paul L, Mousny M, Cornu O, Delloye C. The use of allografts in paediatric orthopaedic surgery. Acta Orthop Belg. 2007;73:551–7.
  3. Engh GA, Ammeen DJ. Use of structural allograft in revision total knee arthroplasty in knees with severe tibial bone loss. J Bone Joint Surg Am. 2007;89:2640–7.
  4. Nevins M, Hanratty J, Lynch SE. Clinical results using recombinant human platelet-derived growth factor and mineralized freeze-dried bone allograft in periodontal defects. Int J Periodontics Restorative Dent. 2007;27:421–7.
  5. Gok A, Erkutlu I, Alptekin M, Kanlikama M. Three-layer reconstruction with fascia lata and vascularized pericranium for anterior skull base defects. Acta Neurochir (Wien). 2004;146:53–6.
  6. Errani C, Schuster S, Biagini R, et al. Reconstruction with fascia lata allograft of the posterior vertebra elements after resection for aneurysmal bone cyst in a child. Eur Spine J. 2007;16:1531–5.
  7. Dufrane D, Mourad M, van Steenberghe M, Goebbels RM, Gianello P. Regeneration of abdominal wall musculofascial defects by a human acellular collagen matrix. Biomaterials. 2008;29:2237–48.
  8. Jang YJ, Wang JH, Sinha V, Song HM, Lee BJ. Tutoplast-processed fascia lata for dorsal augmentation in rhinoplasty. Otolaryngol Head Neck Surg. 2007;137:88–92.
  9. Delloye C. Tissue allografts and health risks. Acta Orthop Belg. 1994;60(Suppl 1):62–7.
  10. Carlson ER, Marx RE, Buck BE. The potential for HIV transmission through allogeneic bone. A review of risks and safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:17–23.
  11. Conrad E U, Gretch D R, Obermeyer K R, Moogk M S, Sayers M, Wilson J J, Strong D M, Transmission of the hepatitis-C virus by tissue transplantation. : , 10.2106/00004623-199502000-00007
  12. Tomford W W, Transmission of disease through transplantation of musculoskeletal allografts. : , 10.2106/00004623-199511000-00017
  13. Eastlund T. Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank. 2006;7:147–66.
  14. Lelie PN, Zaaijer HL, Cuypers HT. Risk of virus transmission by tissue, blood, and plasma products. Transplant Proc. 1996;28:2939.
  15. Pinkowski JL, Rodrigo JJ, Sharkey NA, Vasseur PB. Immune response to nonspecific and altered tissue antigens in soft tissue allografts. Clin Orthop Relat Res. 1996;326:80–5.
  16. Pinkowski JL, Reiman PR, Chen SL. Human lymphocyte reaction to freeze-dried allograft and xenograft ligamentous tissue. Am J Sports Med. 1989;17:595–600.
  17. Minami Akio, Usui Masamichi, Ishii Seiichi, Kobayashi Hiroshi, The in vivo effects of various immunoreactive treatments on allogeneic tendon grafts, 10.1016/s0363-5023(83)80088-4
  18. Minami A, Ishii S, Ogino T, Oikawa T, Kobayashi H. Effect of the immunological antigenicity of the allogeneic tendons on tendon grafting. Hand. 1982;14:111–9.
  19. Dufrane D, Marchal C, Cornu O, Raftopoulos C, Delloye C. Clinical application of a physically and chemically processed human substitute for dura mater. J Neurosurg. 2003;98:1198–202.
  20. Dufrane D, Cornu O, Delloye C, Schneider YJ. Physical and chemical processing for a human dura mater substitute. Biomaterials. 2002;23:2979–88.
  21. Anastasescou M, Cornu O, Banse X, Konig J, Hassoun A, Delloye C. Ethanol treatment of tendon allografts: a potential HIV inactivating procedure. Int Orthop. 1998;22:252–4.
  22. Dufrane D, Delloye C, McKay IJ, et al. Indirect cytotoxicity evaluation of pseudowollastonite. J Mater Sci: Mater Med. 2003;14:33–8.
  23. Papadimitriou E, Lelkes PI. Measurement of cell numbers in microtiter culture plates using the fluorescent dye Hoechst 33258. J Immunol Methods. 1993;162:41–5.
  24. Dufrane D, Steenberghe M, Goebbels RM, Saliez A, Guiot Y, Gianello P. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials. 2006;27:3201–8.
  25. Thaunat O, Badet L, El Jaafari A, Kanitakis J, Dubernard JM, Morelon E. Composite tissue allograft extends a helping hand to transplant immunologists. Am J Transplant. 2006;6:2238–42.
  26. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401–11.
  27. Elves MW, Salama R. A study of the development of cytotoxic antibodies produced in recipients of xenografts (heterografts) of iliac bone. J Bone Joint Surg Br. 1974;56:331–9.
  28. Stevenson S. Biology of bone grafts. Orthop Clin North Am. 1999;30:543–52.
  29. Skjodt H, Moller T, Freiesleben SF. Human osteoblast-like cells expressing MHC class II determinants stimulate allogeneic and autologous peripheral blood mononuclear cells and function as antigen-presenting cells. Immunology. 1989;68:416–20.
  30. Moreau MF, Gallois Y, Basle MF, Chappard D. Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. Biomaterials. 2000;21:369–76.
  31. Wozniak Michele A, Modzelewska Katarzyna, Kwong Lina, Keely Patricia J, Focal adhesion regulation of cell behavior, 10.1016/j.bbamcr.2004.04.007
  32. Rosso F, Giordano A, Barbarisi M, Barbarisi A. From cell-ECM interactions to tissue engineering. J Cell Physiol. 2004;199:174–80.
  33. Martins AM, Santos MI, Azevedo HS, Malafaya PB, Reis RL. Natural origin scaffolds with in situ pore forming capability for bone tissue engineering applications. Acta Biomater. 2008;4:1637–45.
  34. Montanaro L, Arciola CR, Campoccia D, Cervellati M. In vitro effects on MG63 osteoblast-like cells following contact with two roughness-differing fluorohydroxyapatite-coated titanium alloys. Biomaterials. 2002;23:3651–9.
  35. Cheung DT, Perelman N, Tong D, Nimni ME. The effect of gamma-irradiation on collagen molecules, isolated alpha-chains, and crosslinked native fibers. J Biomed Mater Res. 1990;24:581–9.
  36. Bowes JH, Moss JA. The effect of gamma radiation on collagen. Radiat Res. 1962;16:211–23.
  37. Bailey AJ, Rhodes DN, Cater CW. Irradiation-induced crosslinking of collagen. Radiat Res. 1964;22:606–21.
  38. Davidson R. J., Cooper D. R., The effect of γ-irradiation on soluble collagen, 10.1042/bj1070029
  39. Leontiou I, Matthopoulos DP, Tzaphlidou M, Glaros D. The effect of gamma irradiation on collagen fibril structure. Micron. 1993;14:13–6.
  40. Friedlaender GE, Strong DM, Tomford WW, Mankin HJ. Long-term follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am. 1999;30:583–8.
  41. Horowitz M C, Friedlaender G E, Induction of specific T-cell responsiveness to allogeneic bone. : , 10.2106/00004623-199173080-00004
  42. Gouk Sok-Siam, Lim Tit-Meng, Teoh Swee-Hin, Sun Wendell Q., Alterations of human acellular tissue matrix by gamma irradiation: Histology, biomechanical property, stability,in vitro cell repopulation, and remodeling, 10.1002/jbm.b.30862